Vachadi Gana and Haridradi Gana Kala Basti in Dyslipidemia

Comparative Clinical Evaluation of Vachadi Gana and Haridradi Gana Kala Basti in Dyslipidemia - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/09/094539

Enrollment

Registered

2025-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing for trial with consent. Patients who are fit for Basti.

Exclusion criteria

Exclusion criteria: Patients having serious ailments like Insulin Dependant Diabetes Mellitus or poorly controlled Diabetes Mellitus, Myocardial Infarction, Cardiac failure, Renal insufficiency, Hypothyroidism, Malignancies, gluco-corticosteroids induced dyslipidaemia. Patients with Secondary Dyslipidemia. Patients unfit for Basti. Patients on statins/any other drug. Pregnant females and lactating mothers.

Design outcomes

Secondary

Measure	Time frame
Changes in levels of Total Cholesterol, Triglycerides, LDL & HDLTimepoint: 8 WEEKS	—

Primary

Measure	Time frame
Reduced Levels of Lipid ProfileTimepoint: 3 WEEKS	—

Countries

India

Contacts

Public ContactDr Shrimant Gangaram Chavan

Himalayiya Ayurvedic Pg Medical College And Hospital

drshrimantgc.bc@gmail.com7204863633

Outcome results